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The minor capsid protein L2 of papillomaviruses (PVs) likely plays a role in the selective encapsidation of PV DNA in viral
capsids and in the infectivity of PV virions. The L2 protein also can cause the relocalization of the PV early protein, E2TA, to
nuclear subdomains known as promyelocytic leukemia oncogenic domains (PODs) in which it is localized. E2TA is a
transcriptional transactivator that also plays a critical role in viral DNA replication. In this study, we investigated whether L2,
in causing the relocalization of E2TA, alters the activities of E2TA. We provide evidence that L2 inhibits the transcriptional
transactivation function of E2, but it does not specifically inhibit the capacity of E2 to support viral DNA replication. We also
investigated whether the colocalization of E2 and L2 to PODs and the ability of L2 to inhibit the transcriptional transactivation
activity of E2TA might be mediated through a direct interaction between these two proteins. Using an in vitro protein–protein
association assay, we found that L2 binds to E2TA. Two regions in E2TA were found to mediate this interaction. One of those
domains is present in an alternative E2 gene product, E2TR, which is an antagonist to E2TA. Here we show that the L2 protein
also relocalizes the E2 transcriptional repressor, E2TR, to the nuclear subdomains. These data suggest that the ability of L2
to relocalize E2 proteins to PODs is mediated through a direct interaction with L2. © 2000 Academic Press
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EINTRODUCTION
Papillomaviruses (PVs) are small, nonenveloped, icosa-
hedral DNA viruses of about 55 nm in diameter that repli-
cate in the nucleus of epithelial cells. They display strict
species and tissue specificity and induce squamous epi-
thelial or fibroepithelial tumors in their natural hosts. The
size of the genome is about 8 kb, and it is divided in early
and late regions. The open reading frames (ORFs) of the
early region are identified as E1–E8, and those of the late
region are identified as L1 and L2. The early genes are
involved in the regulation of viral gene expression, viral
genomic DNA replication, and cellular transformation. The
late genes code for structural proteins that are required in
the formation of virus particles. The long control region
contains many cis regulatory elements involved in viral
replication and transcription.
PVs cause the formation of warts and benign tumors,
which in the case of some PVs can progress to carcino-
mas. PVs infect basal cells of epidermis at sites of
wounding. The life cycle of the virus is separated into two
phases: the nonproductive, plasmid maintenance and
the productive, vegetative amplification phase. These
two stages of the viral life cycle are linked to the differ-
entiation stage of the epithelial cells, where the nonpro-1 To whom reprint requests should be addressed. E-mail: lambert@
ncology.wisc.edu.
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304ductive phase is supported by undifferentiated cells and
the productive phase is supported by differentiated cells.
In the maintenance phase, the viral genome is replicated
at low copy number, and only the early genes are ex-
pressed. As the epithelial cells differentiate, the “late”
gene expression is turned on, and structural proteins are
expressed, viral DNA is further amplified, and progeny
virions are produced.
The E2TA protein is a transcriptional transactivator
(Spalholz et al., 1985) that enhances transcription from
ultiple viral promoters by its ability to bind as a dimer to
DNA recognition element that is found in multiple
opies on the viral genome. In addition to its DNA bind-
ng and dimerization properties, the N-terminus of E2TA
ontributes to transactivation (Lambert et al., 1989; Sakai
t al., 1996). In addition to the full-length E2 protein,
PV-1 encodes two shorter forms of the E2 protein, the
2 transcriptional repressors (E2TR) and E8/E2TR, which
ere named for their ability to inhibit the transactivation
ctivity of E2TA (Choe et al., 1989; Lambert et al., 1990,
987). They are encoded by the 39 half of the E2 ORF.
2TR is expressed from the p3080 promoter and is initiated
at an internal initiation codon at residue 162. E8/E2TR is
encoded by a spliced message so that the first 11 amino
acids are encoded by E8 ORF and joined to the C-
terminal 205 amino acids of E2. Both E2TR and E8/E2TR
can modulate the function of E2TA in transcription. They
are thought to do so either by forming heterodimers that
are attenuated in transactivational activity or by compet-
r
c
a
t
t
v
r
(
s
s
b
M
d
n
g
a
i
s
c
v
a
v
g
305PAPILLOMAVIRUS VIRAL CAPSID PROTEIN L2ing, as homodimers, for E2 binding sites on the viral
genome (Barsoum et al., 1992; McBride et al., 1988).
The full-length E2 facilitates viral DNA replication
through cooperative binding to the origin of replication
with the E1 protein. The E1 protein is a DNA helicase that
is essential for the replication of viral DNA in rodent cells
and in vitro. For BPV DNA replication, both the E1 and
E2TA proteins are needed in trans (Ustav and Stenlund,
1991). The cis element necessary and sufficient for DNA
eplication is referred to as the origin (ori) of DNA repli-
ation (Ustav et al., 1991). The E2TA protein can associ-
te with E1 protein and increases the binding E1 protein
o its recognition element in ori. Thus E2TA likely con-
ributes to replication by facilitating E1 binding to the
iral replicon. Other studies suggest that E2TA plays a
ole in mediating viral DNA segregation in dividing cells
Ilves et al., 1999) by binding to the metaphase chromo-
omes and in this way facilitating the viral genomes to
egregate to daughter cells in approximately equal num-
ers (Lehman and Botchan, 1998; Skiadopoulos and
cBride, 1998).
As infected epithelial cells progress through terminal
ifferentiation, the viral genome is amplified to high copy
umber, and all viral genes, including the “late” structural
enes L1 and L2, that encode the viral capsid proteins
re expressed and viral capsids are formed. The capsid
s composed of 60 hexavalent and 12 pentavalent cap-
omeres. Each capsomere is a pentamer of the major
apsid protein, L1. The L1 protein can self-assembly into
irus-like particles (VLPs) (Zhou et al., 1991), even in the
bsence of L2. These VLPs have been shown to have
ery similar capsid structure to virions (Heino et al., 1995;
Kirnbauer et al., 1992, 1993). The PV capsid contains L1
and L2 proteins in a molar ratio estimated at approxi-
mately 30:1. The exact location of the minor capsid pro-
tein, L2, is not known. The ability of an antibody to L2 to
neutralize PV infectivity demonstrates that a portion of
the protein is exposed on the surface of the capsid
(Christensen et al., 1991; Heino et al., 1993). Although
hexavalent and pentavalent capsomeres form star-
shaped pentamers of the L1 protein, they have distinct
high-resolution structures. L2 protein is speculated to be
located in the center of the pentavalent capsomeres
(Trus et al., 1997).
The exact role of the L2 protein in virus life cycle is still
unclear. The viral genome has been shown to be pack-
aged into VLPs composed of both L1 and L2 proteins but
not into capsids composed of L1 only. The requirement of
L2 protein for genome encapsidation and its ability to
bind DNA nonspecifically in vitro (Zhou et al., 1994) sug-
gest that L2 contributes to the packaging of the viral
DNA. Both capsid proteins are required to generate in-
fectious virus (Volpers et al., 1995; Zhou et al., 1993).The E2TA and L2 proteins of BPV-1 have been shown
to colocalize to subdomains of the nucleus when thesetwo proteins are overexpressed in cells. These sub-
nuclear domains, where E2TA and L2 proteins colocal-
ize, are promyelocytic leukemia (PML) oncogenic do-
mains (PODs) (Day et al., 1998). The exact role of PODs
is unknown. They were originally identified by immuno-
staining with antisera from patients with primary biliary
cirrhosis. PML, encoded by a gene mutated in acute
promyelocytic leukemia (APL), localizes to these nuclear
domains. The t(15;17) chromosome translocation in APL
cells fuses PML to the retinoic acid receptor-a (RARa)
ene to form oncoprotein PML-RARa. PODs in APL cells
are disrupted, and disruption of PODs has suggested to
play a general role in carcinogenesis. Viral proteins from
multiple virus types are associated with PODs. Several
regulatory proteins encoded by DNA viruses target
PODs at very early times of infection. Early steps of
transcription and replication of some DNA virus families
(Ad5, HSV-1, SV40) take place at the peripheries of PODs
(Ahn et al., 1998; Ahn and Hayward, 1997; Carvalho et al.,
1995; Maul et al., 1996; Szekely et al., 1996). Proteins of
certain DNA virus families interact with PODs without
changing their structure, whereas proteins from other
virus families destroy or reorganize the structure of
PODs. However, at this point it is not clear what role
interactions between PODs and viruses play in the viral
life cycle of different viruses.
In this study, we show that the L2 protein of BPV-1
modulates the transcriptional transactivation function of
the E2TA protein but not E2TA’s role in viral DNA repli-
cation. Using an in vitro protein–protein association as-
say, we show that E2TA binds L2. In the E2TA protein, we
identified two domains, one in the amino-terminus and
the other in the middle of E2TA, that independently me-
diate binding to L2. The L2 protein is known to recruit
E2TA protein to nuclear subdomains. Here we show that
in addition to relocalizing the full-length E2TA to nuclear
subdomains, the L2 protein also recruits the E2 tran-
scriptional repressor, E2TR, to nuclear subdomains.
RESULTS
The L2 protein of BPV-1 modulates the transcriptional
transactivator, E2TA
The full-length E2 protein of BPV-1 is a transcriptional
transactivator. It has been shown that L2 protein relocal-
izes the E2TA protein to subdomains of the nucleus. To
learn whether the L2 protein modulates the transcrip-
tional transactivation function of E2TA, we monitored the
transcriptional activity of E2TA in transient transfection
assays using the reporter plasmid pBS1073. In the
pBS1073 plasmid, the luciferase gene is expressed from
the minimal thymidine kinase promoter, of which four E2
binding sites (E2BS) are positioned upstream. The cal-
cium phosphate precipitation method was used to co-
transfect the E2TA expression plasmid pC59 into the
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306 HEINO, ZHOU, AND LAMBERTCV-1, 3T3–10:3, or 293 cells with the luciferase reporter
plasmid pBS1073. High levels of luciferase were ex-
pressed in these cells (Fig. 1). To determine whether the
L2 protein has an effect on the activity of the E2 tran-
scriptional transactivator, we cotransfected pC59 and
pBS1073 plasmids along with the L2 expression plasmid
pcDNAHBL2. In the absence of any L2 protein, a strong
activation of luciferase gene expression was seen (Fig.
1). However, when increasing amounts of the L2 expres-
sion plasmid were cotransfected into the cells, the lucif-
erase activity was decreased (Fig. 1). The luciferase
activity from experiments in which no L2 protein was
present (equivalent amounts of the parental vector
pcDNA3 were transfected into the cells) was compared
with luciferase activity from experiments in which L2
expression plasmid pcDNAHBL2 was cotransfected into
cells. In the multiple cell types that were assayed, the
levels of luciferase activity found in cells expressing L2
were 1–13% of the activity found in cells not expressing
L2 (Table 1). In control experiments in which we used
plasmids with promoters that are not responsive to the
E2TA protein, the effect of the L2 protein was minimal
compared with its effect on E2TA-dependent transcrip-
tion (Table 1). From these experiments, we conclude that
FIG. 1. Repression of E2-dependent luciferase expression from
pBS1073 by increasing amounts of L2 protein. In the y axis are shown
the relative luciferase units, and in the x axis are shown the amounts
of L2 expression plasmid pcDNAHBL2 cotransfected into CV-1 cells.
Shown are the average luciferase activities of an experiment with five
different L2 concentrations. Each experiment was performed in tripli-
cate. In each experiment, 1 mg of pBS1073, 0.1 mg of E2 expression
lasmid pC59, and 0–7.5 mg of L2 expression plasmid pcDNAHBL2
were cotransfected into cells. The L2 protein is expressed from the
CMV-promoter in the pcDNA3 plasmid. Within the experiment, we
controlled for any effect of the CMV-promoter itself by maintaining the
total amount of the parental plasmid, pcDNA3, constant throughout the
experiments (e.g., 7.5 mg of pcDNA3 was cotransfected into cells when
o L2 expression plasmid was used in transfections). Error bars indi-
ate standard deviations.the L2 protein affects the transcriptional transactivation
function of the E2TA protein.
eThe L2 protein of BPV-1 does not specifically
modulate the replication function of E2TA
In addition to its transcriptional transactivator func-
tions, the E2TA protein of papillomaviruses is known
together with the viral replication protein, E1, to play a
role in viral replication. To determine whether the L2
protein has an effect on the replication function of the
E2TA protein, transient replication assays were carried
out. The BPV-1 replicon pRLH89.7 contains BPV-1 long
control region (LCR) (nt 7350–90) and includes the min-
imal origin of replication (nt 7914–27). The E1 and E2TA
proteins were expressed in trans from cytomegalo-
virus (CMV) immediate-early promoter from plasmids
pCGEag1235 and pC59, respectively. pCGEag1235 car-
ries a point mutation at nt 1235 that destroys a splice
donor sequence at this site, leading to more efficient
production of E1 protein. The plasmids pCGEag1235 and
pC59, along with the replicon pRLH89.7, were introduced
into CV-1, 3T3 10:3, or 293 cells by the calcium phosphate
precipitation method. The ratio of the concentration of
pC59 and pcDNAHBL2 plasmids used in these replica-
tion assays was the same as the ratio used for the
transcriptional activation assays described earlier. Low-
molecular-weight (Hirt) DNA was isolated 3 days post-
transfection, digested with BglII and DpnI, and analyzed
by Southern hybridization analyses with a BPV-1-specific
probe. DpnI cleaves the DNA sequence GATC only if the
adenine residue is methylated as occurs in bacteria.
Thus DpnI cleaves all DNA from the bacterial origin. DNA
that has undergone replication in mammalian cells is not
methylated at the adenine in this sequence context and
therefore is resistant to DpnI cleavage. BglII linearizes
the pRLH89.7 replicon. Efficient replication of the origin
TABLE 1
Inhibition of Transcriptional Transactivation Function
of E2TA by L2 Protein
Reporter
plasmid Promoter
Relative luciferase activitya
3T3 CV-1 293
pBS1073
1 pC59
HSV Tk 1 4E2BS 0.02 6 0.02 0.13 6 0.05 0.01 6 0.02
pBS1013 HSV Tk 0.19 6 0.09 0.56b 0.31 6 0.13
pBS1065 CMV 0.22 6 0.04 1.21c ND
pGLcontrol SV40 0.22d 0.97e 0.25 6 0.18
Note. ND, not done.
a Shown are the relative luciferase activities from experiments where
2 was present to the luciferase activity from experiments where no L2
as present. Unless otherwise indicated, experiments were performed
hree or more times. In each experiment, samples were determined in
riplicate.
b Experiment was performed only once.
Experiments were performed twice. The relative values of eachxperiment are as follows: c 0.30 and 2.12, d 0.26 and 0.18, and e 0.41
and 1.53.
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307PAPILLOMAVIRUS VIRAL CAPSID PROTEIN L2containing plasmid pRLH89.7 was dependent on the
presence of both E1 and E2TA proteins (Fig. 2, lane 3). In
the absence of E2, we detected low levels of replication
(Fig. 2, lane 1) of pRLH89.7 consistent with prior studies
in vitro (Bonne-Andrea et al., 1995; Muller et al., 1994) and
n similar types of transient replication assays on HPV-1
Gopalakrishnan and Khan, 1994). In these independent
xperiments, L2 led to a 1.8-fold decrease in the levels of
eplication in the absence of E2 (Fig. 2, lanes 1 and 2). A
imilar 2.7-fold decrease was observed in the presence
FIG. 2. Effect of L2 on the replication function of E2. Shown are
phosphorimages of BPV-1-specific Southern blots in which Hirt DNA
was isolated from 293 cells 3 days after transfection. Eight micrograms
of the reporter plasmid pRLH89.750, 50 ng of the E1 expression plas-
mid pCGEag1235, and 0 or 300 ng of E2 expression plasmid pC59 were
cotransfected with or without the L2 expression plasmid, pcDNAHBL2,
into 293 cells as shown. BglII linearizes the reporter plasmid,
pRLH89.750. Lanes 1–4 in the upper panel contain BglII-digested Hirt
DNA (4 ml). The reporter and the recovery plasmids are indicated by
rrows. The corresponding lanes (1–4) in the lower panel contain the
ame Hirt DNAs (20 ml) digested with DpnI and BglII. The recovery
plasmid was not detected in this lower panel, indicating complete DpnI
digestion (note five times more DNA was loaded in the lower panel).
Therefore, the signal for reporter plasmid pRLH89.750 detected in this
lower panel represents DNA that has replicated in eukaryotic cells. In
the first two lanes, Hirt DNA was isolated from cells that were trans-
fected with 50 ng of E1 expression plasmid in the presence (lane 2) or
absence (lane 1) of L2 expression plasmid. The lanes 3 and 4, respec-
tively, are Hirt DNA samples from cells in which 300 ng of E2 expres-
sion plasmid was cotransfected in addition to the plasmids used for
transfections in lanes 1 and 2.f E2 (Fig. 2, lanes 3 and 4). The corresponding values in
nother experiment were 1.3- and 2.2-fold, respectively.These data indicate that L2 can inhibit slightly viral DNA
replication in 293 cells, but this inhibition was not de-
pendent on E2. The degree of inhibition of replication
was small compared with the degree of inhibition of
E2-mediated transcription in this same cell line (100 fold;
see Table 1), suggesting that L2 preferentially inhibits the
transactivation activity of E2. Similar studies carried out
in 3T3 cells demonstrated an absence of any significant
effect of L2 on E2-dependent or E2-independent replica-
tions (data not shown); further supportive of the conclu-
sion that L2 is largely affecting only the transcriptional
activation activities of E2TA. Here, the lack of an effect of
L2 on replication was evident at varying levels of E1 and
E2TA DNA tested (data not shown).
The E2TA protein of BPV-1 interacts directly with the
minor capsid protein L2
To learn whether L2 relocalized E2TA within the nu-
cleus and modulates the transactivation function of E2TA
via a direct interaction with E2TA, we sought the potential
association of E2TA and L2 proteins by using an in vitro
protein–protein association assay. E2TA was overex-
pressed in Escherichia coli as a GST-E2TA fusion pro-
tein, batch-purified using glutathione–Sepharose, and in-
cubated with in vitro translated 14C-labeled L2 protein.
he level of nonspecific binding by L2 in this assay was
etermined by incubating L2 protein with GST-b-globin
bG). In multiple experiments, the GST-E2TA fusion pro-
ein was found to bind at approximately 10% of the input
2 protein, which was 5- to 10-fold greater than the
ackground binding to GST-bG (Fig. 3).
To identify the domain or domains in the E2TA protein
that mediate binding to the L2 protein, we performed
similar in vitro protein–protein association assays by
using derivatives of GST-E2TA deleted from various por-
tions of E2TA. The N-terminal 52 amino acids of E2TA
were sufficient for efficient binding to L2 (Fig. 4). Another
independent binding site in E2TA was found in the C-
terminal portion of E2TA as judged by the strong binding
of GST-E2 93–410 to L2 (Fig. 4). This strong binding was
also seen when this region was reduced to amino acids
(aa) 93–283. When we further dissected aa 93–410 into
two separate domains, aa 93–161 and aa 162–410, effi-
cient binding to L2 was lost (Fig. 4). Thus the domain
from 93–283 appears to define the second L2 associa-
tion domain. However, we also saw efficient binding
when we fused aa 52–91 to aa 162–410. Thus sequences
from aa 52–93 or aa 93–161, each of which do not in of
themselves support L2 binding, can support efficient
binding to L2 when fused to the C-terminal half of the E2
protein from 162–410 and/or 162–283. One possible ex-
planation for this result is that some peptide motif dupli-
cated in aa 52–91 and 93–161 partially contributes to
specific L2 binding. However, no obvious duplication of
amino acid sequence can be found in these two regions.
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“spacer” function to separate GST from the C-terminus of
E2TA, thereby permitting efficient binding by the C-termi-
nus of E2TA to L2.
We further analyzed whether the capacity of the two
fusion proteins harboring the two separate L2 interaction
domains (GST-E2 1–52 and GST-E2 52–91/162–410) to
bind L2 was specific. The capacity of these two fusion
proteins to bind two irrelevant proteins, luciferase and
retinoblastoma, was investigated. The 35S-labeled lucif-
erase or retinoblastoma proteins bound the GST-E2 1–52
and GST-E2 52–91/162–410 fusion proteins at about
same levels as the GST-bG (Table 2). The results of this
analysis indicate that these two domains in E2 display
specificity for L2.
E2TR, the transcriptional repressor, colocalizes with
L2 protein in nucleus
Our protein–protein association studies led to the pre-
diction that the relocalization by L2 of E2TA to subdo-
mains of the nucleus may be mediated by an association
between these two proteins. Based on our mutational
FIG. 3. L2 binds to E2TA. Binding of in vitro synthesized L2 to
ST-E2TA fusion protein in four different reactions. The 14C-labeled in
itro translated L2 protein was incubated with GST-E2TA (lane 1) or
ST-bG (lane 2) coupled to glutathione–Sepharose beads. After the
washes, proteins bound to beads were eluted, resolved on an SDS–
polyacrylamide gel, and analyzed by autoradiography and phosphorim-
aging. In vitro translated 14C-labeled L2 protein included in each bind-
ng reaction was loaded directly in the lane 3. In the first experiment,
he L2 input was 5%, and in experiments 2–4, the input was 10%. Shown
n the right is the fold of binding of L2 input protein to GST-E2TA over
ts binding to GST-bG, as determined by phosphorimaging analysis.
rrows indicate the site of L2.analysis of E2TA data, the second domain of E2TA that
binds to L2 may be completely contained within a sec-ond E2 gene product, called E2 transcriptional repressor,
or E2TR (Fig. 5). E2TR is encoded by the 39 half of the E2
ORF and functions as transcriptional repressor. To study
whether E2TR colocalizes with L2 in the nucleus, we
compared the immunofluorescent (IF) staining patterns
of E2TA and E2TR in cells that did or did not express L2
protein.
A strong nuclear staining of L2 protein was seen by IF
in cells transfected with the pcDNAHBL2, showing that
the L2 protein was effectively expressed from the
pcDNAHBL2, with “humanized” codons of L2 ORF (Fig.
6). In a large portion of the cells, the L2 protein localizes
to nuclear subdomains. In COS cells expressing the
full-length E2 protein only, in the absence of any L2
protein, usually a diffuse nuclear staining, sometimes
with one or two darker spots, is seen with E2 antibodies
by IF staining (Fig. 6d). The presence of the L2 protein
causes relocalization of E2TA to nuclear subdomains,
and a punctate staining pattern of both E2TA and L2 is
commonly seen in the nucleus (Fig. 6a) as described
previously (Day et al., 1998). To study whether the shorter
FIG. 4. Various derivatives of the E2 protein were synthesized as the
GST fusion. Binding of the different fusion proteins to in vitro translated
L2 was assessed in an in vitro protein association assay. Shown on the
left are the amino acids of the E2 protein included in each GST fusion
protein. On the right are data from corresponding GST pull-down
assays. In each experiment, the percentage of input protein L2 bound
to various GST-E2 derivatives was quantified by phosphorimaging
analysis and compared with same amount of the input protein L2
bound to GST-E2TA. Each experiment was performed 3—10 ten times.
Error bars indicate standard deviations.
TABLE 2
Relative Binding Compared with GST-bG
L2 Rb Luc
ST-E2, 1–52 6.8a 1.3 1.8
GST-E2, 52–91/162–410 8.3 1 1.1Experiments were performed two times except the aexperiment that
was performed three times. Shown are average values.
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309PAPILLOMAVIRUS VIRAL CAPSID PROTEIN L2form of the BPV-1 E2 protein, E2TR was colocalized with
L2 in the nucleus, the E2TR expression plasmid pCGE2C
was cotransfected with pcDNAHBL2 into COS cells.
When E2TR protein was expressed without any L2 pro-
tein, mostly a diffuse nuclear staining of E2TR was seen.
However, when E2TR was coexpressed with L2, a punc-
tate staining pattern of E2TR was seen in the nuclei of
these cells, indicating that L2 relocalizes also E2TR to
nuclear subdomains (Fig. 7).
DISCUSSION
In this study, we have shown that the minor capsid
protein, L2, is able to modulate the transcriptional trans-
activation function of the E2TA protein of BPV-1. Using an
in vitro protein–protein association assay, we demon-
strated that L2 binds to E2TA in vitro. We could identify
two domains in E2TA that independently bound L2. The
L2 protein relocalizes E2TA to nuclear subdomain, which
has been shown by others to be PODs (Day et al., 1998).
e have demonstrated that the L2 protein also relocal-
zes E2TR to nuclear subdomains and is colocalized with
2TR in these nuclear subdomains.
In the absence of L2, E2TA retains its transcriptional
ransactivation function, and mostly a diffuse nuclear
taining, sometimes with one or two darker spots of the
2TA protein, is seen in these cells. However, in the
resence of L2, the E2TA protein is colocalized with L2,
ften to subdomains of the nucleus. At the same time, it
eems to lose at least one of its activities, transcriptional
ransactivation, but it retains its function in replication.
he relocalization of E2TA to the nuclear subdomains
ay be the reason it does not function as transcriptional
ransactivator. Alternatively, L2 may directly interfere with
he binding of E2TA to cellular transcription factors that
FIG. 5. Binding of the E2TA protein to the L2 protein of BPV-1. Shown
at top are the alignments of the coding regions of E2TA and E2TR
proteins. Numbers indicate the amino acid residues in the E2 ORF of
BPV-1. The shaded boxes represent the conserved amino- and carbox-
yl-terminal domains among PVs. Shown are the two putative binding
domains of E2 that independently bound L2. Both L2 binding domains
overlap with TAF70 binding domains (N. M. Rank, H. Lu, A. J. Levine,
and P. F. Lambert, unpublished observations).ediate the transactivation activity of the latter. The in-
uction of gene expression by E2TA protein of BPV-1
t
erequires an interaction between E2TA and cellular fac-
tors that leads to the formation of an activated RNA
polymerase complex. The E2TA protein of BPV-1 has
been shown to directly bind to TATA binding protein
(TBP) (Rank and Lambert, 1995) and to human TBP-
associated factor (TAF) hTAFII70 (N. M. Rank, H. Lu, A. J.
Levine, and P. F. Lambert, unpublished observations),
both of which are subunits of the cellular transcription
factor IID (TFIID). The basal transcription factor IIB
(TAFIIB) is an essential component of the RNA polymer-
ase II transcription apparatus. The E2TA protein of BPV-1
binds to and functionally interacts with TFIIB (Benson et
al., 1997; Rank and Lambert, 1995; Yao et al., 1998).
Two domains in E2TA bind independently to L2 as
shown in in vitro protein–protein association assays. The
second domain that bound to L2 appears to overlap with
a second E2 gene product, E2TR. Confocal microscopic
studies revealed that E2TR also is colocalized with L2,
whereas a diffuse nuclear staining is usually seen in the
absence of the L2 protein. These data are consistent
with the hypothesis that the direct association between
L2 and E2 mediates their colocalization. It also raises the
possibility that L2 modulates the activity of more than
one E2 protein family member.
The present study shows that the L2 protein interferes
with the transcriptional transactivation function of the
E2TA protein but to a lesser degree or not at all with the
replication function of E2TA. It is presumed that the mode
of viral DNA replication in the transient replication assay
used here reflects that which occurs early in the estab-
lishment of the nonproductive stage of the viral infection
(i.e., a theta mode of viral DNA replication). In contrast,
viral DNA replication in the productive stage of the viral
life cycle, when L2 is selectively expressed, is thought to
occur through a rolling circle mode (Flores and Lambert,
1997). Further studies are necessary to determine
whether L2 interferes with the predicted role of E2TA in
the viral DNA amplification during the productive stage of
the viral life cycle (Alderborn et al., 1992).
The nuclear subdomains where E2TA and L2 proteins
colocalize are PODs, which may play a role in cellular
antiviral defense because infection, such as with HSV-1,
adenovirus, and human CMV, disrupts PODs (Ahn et al.,
1998; Ahn and Hayward, 1997; Carvalho et al., 1995;
Szekely et al., 1996). Association with PODs has also
been speculated to play a positive role in viral replication
(e.g., the localization to PODs may increase the local
concentration of viral products and promote virus assem-
bly, or it may interfere with normal differentiation and/or
apoptotic responses to the viruses and promote pro-
cessing of viral products) (Day et al., 1998). Association
ith PODs may also represent a switch in virus life cycle
rom the nonproductive to the virus-producing, produc-
ive phase. The POD-binding proteins HSV-1 ICPO (Maul
t al., 1996) and Epstein–Barr virus EBNA-5 (Szekely et
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310 HEINO, ZHOU, AND LAMBERTal., 1996), which have been implicated in the escape
from latency, have been speculated to serve an anal-
ogous function for their respective viruses (Day et al.,
1998).
Human PVs are one of the most frequently found
viruses in human cancers, yet little is known about the
life cycle of PVs. Our findings that the minor capsid
protein L2 and the transcriptional transactivator E2TA
of BPV-1 bind to each other in vitro and that the L2
protein modulates the transcriptional transactivation
function of E2TA offer important information about the
gap in our knowledge concerning the productive
phase in the infected cell. The E2TA protein may play
a role in the nonproductive as well as in the productive
phase of PV life cycle. The L2 gene gets turned on in
the productive phase of viral life cycle in the differen-
tiated layers of the epithelium. We have shown that L2
modulates one of the known functions of E2TA: its role
as transcriptional transactivator. Therefore, we hy-
pothesize that L2 can modulate the function of E2TA
during the productive phase of the viral life cycle. The
interaction of E2TA and L2 proteins may also allow
FIG. 6. Colocalization of the E2 and L2 proteins. The 35-mm plates of C
(A–C) or with 1 mg of pCGE2 only (D). After fixing, the cells were double
detected with mouse monoclonal anti-E2 antibody, B201, and Texas Red
detected with rabbit polyclonal anti-L2 antiserum and with FITC-conjug
analyzed by laser scanning confocal system. The same field is shown in
staining in the merged panel, C, indicates coincidence of green and rE2TA to contribute to other activities postulated to be
mediated by L2, such as encapsidation.
p
(MATERIALS AND METHODS
Plasmids
Plasmid pBS1073 is the luciferase reporter construct.
It contains luciferase gene downstream and four E2
binding sites upstream of thymidine kinase promoter of
HSV-1 (T. Gahn and B. Sugden, unpublished data).
pBS1013 is the same plasmid construct without the E2
binding sites (Middleton and Sugden, 1992). Plasmid
p1065 contains the luciferase gene downstream of the
CMV promoter. pC59 expresses the full-length E2 protein
(Yang et al., 1985). pRLH89.7 plasmid contains BPV-1 nt
350–90 inserted into the backbone of pGL2 basic vector
Promega, Madison, WI) in sense orientation. It contains
he intact origin of replication with 12 E2 binding sites.
he pWHBPV101 plasmid (Hubert and Lambert, 1993)
ontains the luciferase gene in p142-6 (Sarver et al.,
982) background. pCGEag1235 is an E1 expression
lasmid that contains a silent point mutation at BPV-1 nt
235 that disrupts a 59 splice signal within E1 gene
Ustav and Stenlund, 1991). The pCGE2 expresses the
ull-length E2 protein of BPV-1, and pCGE2C and
lls were cotransfected with 0.5 mg of pcDNAHBL2 and 0.5 mg of pCGE2
d for immunolocalization of the E2 and L2 proteins. The E2 protein was
sheep anti-mouse secondary antibody (A and D). The L2 protein was
oat anti-rabbit IgG (B). The double immunofluorescence staining was
n panel C is a superimposition of images in panels A and B. The yellow
ning.OS ce
-staine
-linked
ated gCGE8/E2 express the E2 transcriptional repressors
E2TR and E8/E2TR) (Ustav and Stenlund, 1991). The pCG
sition
311PAPILLOMAVIRUS VIRAL CAPSID PROTEIN L2vector directs expression of foreign genes from the
strong immediate-early CMV promoter and contains an
SV40 origin that allows for amplification in the presence
of SV40 T-ag, which is expressed in COS cells. The
pGL3-control vector contains the luciferase gene under
the control of SV40 promoter and enhancer (Promega).
The pcDNAHBL1 and pcDNAHBL2 plasmids express the
viral capsid proteins L1 and L2 of BPV-1, respectively
(Zhou et al., 1999). These plasmids are able to efficiently
produce BPV-1 late proteins in undifferentiated cells.
Because the natural PV late genes frequently include
codons that are rarely used in mammalian cells, which
Dr. J. Zhou hypothesizes helps to restrict PV late gene
expression to terminally differentiated cells, the infre-
quently used codons in BPV-1 L1 and L2 genes were
replaced by conservative codons in pCDNAHBL1 and
pCDNAHBL2. This results in efficient expression of PV
late genes in most cultured mammalian cells. The
pBSBPV1 L2 has the L2 gene of BPV1 inserted into
pBluescript II KS (Stratagene, La Jolla, CA) background (a
gift from Martin Mu¨ller). Luciferase T7 control DNA (Pro-
mega) and p565RB (under T7 control) were used to
express luciferase or retinoblastoma proteins in vitro.
FIG. 7. Colocalization of E2TR and L2 proteins. COS cells were cotra
or with 1 mg of pCGE2 only (D). The L2 protein was detected with rabb
(A). The E2TR protein was detected with mouse monoclonal anti-E2 an
and D). The same field is shown in all panels. Panel C is a superimpo
indicates coincidence of green and red staining.Plasmids pGST-E2TA, pGST-E2TA D1–161 (pGST-E2TA
162–410), pGST-E2TA D1–92 (pGST-E2TA 93–410), and npGST-bG have been described previously (Rank and
Lambert, 1995). Plasmids pGST-E2TA 1–52, pGST-E2TA
D1–92 (pGST-E2TA 93–410), pGST-E2TA 93–161, pGST-
E2TA 53–92, pGST-E2TA 93–283 were generated as de-
scribed (Rank et al., in preparation). The plasmid pGST-
E2TA D1–52,D92–161 (pGST-E2TA 53–91,162–410) was
constructed by PCR amplification of the appropriate cod-
ing region of pGST-E2TA D92–161 (N. M. Rank, H. Lu, A. J.
Levine, and P. F. Lambert, unpublished observations)
from primers designed to contain the glutathione S-trans-
ferase translational ORF and to contain BamHI ends. The
PCR-amplified E2D1–52,D92–161 DNA was cloned into
the BamHI site of the plasmid pGex-3X (Amersham, Ar-
lington Heights, IL).
Fusion protein purification
GST-E2TA and other GST fusion proteins were ex-
pressed and purified as described previously (Rank and
Lambert, 1995). Briefly, cultures (250 ml) were grown at
27°C overnight. An additional 250 ml of Luria-Bertani
medium was added to the overnight cultures, and the
cultures were grown for an additional 3 h at 27°C. IPTG
ed with 0.5 mg of pcDNAHBL2 and 0.5 mg of pCGE2C plasmids (A–C)
lonal anti-L2 antiserum and with FITC-conjugated goat anti-rabbit IgG
B201, and Texas Red-linked sheep anti-mouse secondary antibody (B
of images in panels A and B. Yellow staining in the merged panel, C,nsfect
it polyc
tibody,(isopropyl-b-D-thiogalactopyranoside) was added to a fi-
al concentration of 0.2 mM to induce the expression of
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312 HEINO, ZHOU, AND LAMBERTthe fusion protein, and cells were grown for an additional
3 h at 27°C with minimal shaking. All of the following
steps were performed at 14°C. Cells were pelleted by
centrifugation, resuspended in 10 ml of NET buffer (100
mM NaCl, 1 mM EDTA, 20 mM Tris–HCl, pH 8.0) and
centrifuged again. Cell pellets were resuspended in
NETN-complete buffer [NET buffer, 0.1% Igepal (Sigma
Chemical Co., St. Louis, MO), 1 mM DTT, 13 Protease
inhibitor cocktail) and sonicated in 800-ml aliquots. Cell
ebris was pelleted by centrifugation, and aliquots of the
ell lysates were stored at 270°C.
n vitro protein association assay
The in vitro protein–protein binding assay was per-
ormed as described previously (Rank and Lambert,
995). Briefly, cell lysates containing fusion proteins (4–
00 ml) were incubated with 20 ml of a 50% glutathione–
Sepharose slurry (Pharmacia, Piscataway, NJ), in a final
volume of 200 ml of NETN (NET, 0.5% Igepal) at 4°C for 30
in with rocking. Equimolar amounts of different fusion
roteins were used for each assay. The concentration of
ach fusion protein in each bacterial lysate was as-
essed by Coomassie blue staining of glutathione–
epharose-bound proteins resolved by SDS–PAGE. The
lutathione–Sepharose pellets were washed three times
ith NETN. Fusion proteins coupled to glutathione–
epharose were then incubated for 45 min to 1 h with in
itro translated, 14C-labeled L2 protein or with in vitro
ranslated 35S-labeled luciferase (Promega) or retinoblas-
toma proteins in a final reaction volume of 200 ml of
NETN. Beads were washed as described earlier. Bound
proteins were eluted by boiling for 5 min in 15 ml of 23
DS loading dye and resolved by SDS–PAGE. Radiola-
eled protein that was bound to E2-fusion proteins was
etected by phosphorimaging and autoradiography.
n vitro transcription and translation
The L2 mRNA was transcribed in vitro from the NotI
inearized plasmid, pBSBPV-1 L2, using the Stratagene in
itro transcription system according to the manufactur-
r’s instructions. Flexi Rabbit Reticulocyte Lysate system
Promega) was used to translate L2 protein in vitro using
14C-lysine. TNT-coupled Reticulocyte Lysate system (Pro-
ega) was used to express luciferase and retinoblas-
oma protein in vitro using 35S-methionine.
ransfection of cells
Transfection of cells for immunofluorescent staining.
ells were incubated on coverslips in 35-mm tissue
ulture plates until the cells were 50–70% confluent.
he plasmids used in transfections were pcDNAHBL1,
cDNAHBL2, and pCGE2 and/or pCGE2C. For each
ransfection, 0.5 mg of each plasmid was diluted into 100
ml of serum-free medium. The plasmid solution was then
combined with 10 ml of LipoFECTAMINE in 100 ml of
5
cserum-free medium. The plasmid–LipoFECTAMINE mix-
ture was incubated at room temperature for 20 min. The
cells were rinsed once with 2 ml of serum-free medium.
For each transfection, 0.8 ml of serum- and antibiotic-free
medium was added to the tube containing the com-
plexes, and the complex solution was then overlaid onto
the cells. The cells were incubated from 5 h to overnight
at 37°C. After incubation, the transfection mixture was
removed and replaced with 2 ml of complete medium. At
24 or 36 h after the start of transfection, the cells were
fixed with ethanol or 4% paraformaldehyde. Cells fixed
with paraformaldehyde were permeabilized with 0.5%
Triton X-100.
Transfection of cells for luciferase assay. Transfections
for luciferase assays were performed according to the
calcium phosphate precipitation method (Graham and
van der Eb, 1973) on 50–70% confluent CV-1, 3T3–10:3,
and 293 cells in 6-cm-diameter dishes. Then 1 mg of
pBS1073, 100 ng of pC59, and varying amounts of
pcDNAHBL2 and pcDNA3 were cotransfected into cells.
In control experiments, 1 mg of PBS1013, pBS1065,
pGL3control, or pGL2basic was cotransfected with vary-
ing amounts of pcDNAHBL2 and pcDNA3 into cells. The
total amount of pcDNA derivative DNA was adjusted to
7.5 mg with pcDNA3. Cells were harvested 2 days post-
ransfection, and luciferase assays were performed ac-
ording to the manufacturer’s directions (Promega). Total
ellular protein was quantified by a Bradford assay (Bio-
ad, Hercules, CA). Equal amounts of the total cellular
rotein were used in each luciferase assay.
Transient replication assay. For transient replication
ssays, cells were transfected with the varying amounts
f pCGEag1235 and pC59, with 8 mg of pRLH89.7 and
22.5 mg of either pcDNAHBL2 or pcDNA3 into cells by
alcium phosphate transfection. Replication was scored
sing the pRLH89.7 plasmid that contains BPV-1 LCR
nd includes the minimal origin of replication. In each
xperiment, 2 ng of pWHBPV101 plasmid was added at
he time of DNA extraction as spike DNA to control the
ecovery of low-molecular-weight DNA. Hirt DNA was
solated 3 days posttransfection, digested with BglII with
nd without DpnI, and analyzed by Southern hybridiza-
ion analyses with a BPV-1-specific probe. DpnI cleaves
he DNA sequences of bacterial origin; only in eukaryotic
ells will replicated plasmids be present in DpnI-treated
arget cells. BglII linearizes the pRLH89.7 replicon. The
igested Hirt DNA was analyzed with Southern blotting,
nd replicated DNA was quantified by phosphorimaging
nalysis.
Immunostaining of cells. After rinsing with PBS and
locking with 5% milk in PBS for 10 min at room temper-
ture, the cells fixed in ethanol were incubated with a
ixture of a rabbit anti-L2 and a mouse anti-E2, B201,
ntibody in a dilution of 1:2000 and 1:100, respectively, in
% milk at 14°C overnight. After three PBS washes, the
ells were incubated for 2 h at room temperature with a
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313PAPILLOMAVIRUS VIRAL CAPSID PROTEIN L2mixture of FITC-conjugated goat anti-rabbit immuno-
globulins (Sigma), diluted 1:50, and Texas Red-linked
sheep anti-mouse antibody (Amersham), diluted 1:50.
After three washes in PBS, coverslips with cells were
mounted onto microscope slides using Fluoromount-G
mounting solution (Southern Biotechnology Associates,
Inc.). The double immunofluorescent staining was ana-
lyzed by a laser scanning confocal system (Bio-Rad MRC
1024 Laser Scanning Confocal Microscope).
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